Company Nutra Pharma Corp. Other OTC
Equities
NPHC
US67060U2087
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products and Technologies & Homeopathic and Ethical Drugs
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +88.32% |
Sales per region
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +88.32% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 62 | 16-07-26 | |
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 02-11-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 02-11-06 |
Stewart Lonky
BRD | Director/Board Member | 75 | 04-11-04 |
Garry Pottruck
BRD | Director/Board Member | 65 | 09-07-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 12,000,000 | 0 | 0 | 100.00 % |
Stock B | 1 | 7,596,852,214 | 7,596,852,214 ( 100.00 %) | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+36.75% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |